Skip to search.
 FTSE 100 Up 0.54%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
46.06 Up 0.16(0.35%) 1 Apr 21:00
|After Hours: : 46.06 0.00 (0.00%) 21:30
Add to Portfolio
Prev Close:45.90
Open:45.75
Bid:45.97 x 1800
Ask:46.01 x 300
1y Target Est:43.00
Beta:0.66
Earnings Date:4 May - 8 May (Est.)
Day's Range:45.67 - 46.78
52wk Range:20.23 - 46.96
Volume:1,519,016
Avg Vol (3m):454,397
Market Cap:956.85m
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXUp 0.35%956.85m
ALXNDown 2.19%34.26b
CPIXUp 4.35%117.93m
SLXP 0.00%11.10b

Key Statistics

Forward P/E (1 yr):107.12
P/S (ttm):8.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.68
Quarterly EPS Est (Mar-15) :0.20
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat orphan diseases in the United states, Canada, and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback